Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,339 | 318 | 99.4% |
| Education | $27.81 | 3 | 0.6% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $810.43 | 54 | $0 (2024) |
| Allergan, Inc. | $467.64 | 40 | $0 (2020) |
| PFIZER INC. | $449.96 | 41 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $346.27 | 20 | $0 (2024) |
| Merck Sharp & Dohme LLC | $240.15 | 21 | $0 (2023) |
| GlaxoSmithKline, LLC. | $214.18 | 14 | $0 (2023) |
| Novo Nordisk Inc | $209.89 | 15 | $0 (2024) |
| Ironwood Pharmaceuticals, Inc | $177.80 | 17 | $0 (2018) |
| Astellas Pharma US Inc | $160.62 | 10 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $157.98 | 11 | $0 (2021) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $425.40 | 22 | AstraZeneca Pharmaceuticals LP ($195.28) |
| 2023 | $536.80 | 35 | AbbVie Inc. ($246.08) |
| 2022 | $504.74 | 33 | ABBVIE INC. ($317.48) |
| 2021 | $565.63 | 42 | AbbVie Inc. ($180.03) |
| 2020 | $208.31 | 15 | Allergan, Inc. ($54.24) |
| 2019 | $431.44 | 34 | PFIZER INC. ($129.74) |
| 2018 | $603.56 | 47 | Allergan Inc. ($179.80) |
| 2017 | $1,091 | 93 | Allergan Inc. ($171.73) |
All Payment Transactions
321 individual payment records from CMS Open Payments — Page 1 of 13
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/17/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.91 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/13/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: Respiratory | ||||||
| 11/12/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $14.99 | General |
| Category: DIABETES | ||||||
| 11/07/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.82 | General |
| Category: Respiratory | ||||||
| 09/19/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $13.10 | General |
| Category: Respiratory | ||||||
| 08/19/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $17.21 | General |
| Category: Cardiovascular | ||||||
| 08/13/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $17.80 | General |
| Category: NEUROSCIENCE | ||||||
| 07/29/2024 | SHIELD THERAPEUTICS INC | ACCRUFER (Drug) | Food and Beverage | In-kind items and services | $18.02 | General |
| Category: Hematology | ||||||
| 07/22/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $23.17 | General |
| Category: Biological | ||||||
| 07/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $18.46 | General |
| Category: NEUROSCIENCE | ||||||
| 05/21/2024 | PFIZER INC. | ELIQUIS (Drug), PAXLOVID, NURTEC ODT | Food and Beverage | In-kind items and services | $16.37 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 05/01/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $29.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 04/25/2024 | E.R. Squibb & Sons, L.L.C. | ELIQUIS (Drug) | Food and Beverage | Cash or cash equivalent | $13.19 | General |
| Category: Cardiovascular | ||||||
| 03/28/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $16.16 | General |
| Category: Gastroenterology | ||||||
| 03/27/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.95 | General |
| Category: Respiratory | ||||||
| 03/14/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $13.23 | General |
| Category: Diabetes | ||||||
| 02/14/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.16 | General |
| Category: Diabetes | ||||||
| 02/06/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $20.93 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 02/01/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug), FARXIGA | Food and Beverage | In-kind items and services | $70.30 | General |
| Category: Respiratory | ||||||
| 01/30/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: NEUROSCIENCE | ||||||
| 01/24/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: NEUROSCIENCE | ||||||
| 01/17/2024 | Salix Pharmaceuticals, a division of Bausch Health US, LLC | XIFAXAN (Drug), XIFAXAN, TRULANCE | Food and Beverage | In-kind items and services | $13.78 | General |
| Category: Gastroenterology | ||||||
| 12/06/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $3.54 | General |
| Category: NEUROSCIENCE | ||||||
| 11/08/2023 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $24.52 | General |
| Category: Biological | ||||||
| 10/31/2023 | AbbVie Inc. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $16.33 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 848 | 1,229 | $34,128 | $16,168 |
| 2022 | 17 | 864 | 1,294 | $32,167 | $12,946 |
| 2021 | 7 | 234 | 255 | $12,835 | $4,782 |
| 2020 | 3 | 82 | 108 | $3,541 | $1,169 |
All Medicare Procedures & Services
47 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 87636 | Detection test by multiplex amplified probe technique for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (covid-19) and influenza virus types a and b | Office | 2023 | 21 | 24 | $3,663 | $3,355 | 91.6% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 236 | 383 | $6,063 | $2,908 | 48.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 110 | 202 | $3,998 | $1,923 | 48.1% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 19 | 19 | $1,413 | $1,385 | 98.0% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 68 | 93 | $4,493 | $1,309 | 29.1% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2023 | 24 | 37 | $2,257 | $877.50 | 38.9% |
| 17000 | Destruction of precancer skin growth, 1 growth | Office | 2023 | 12 | 14 | $1,604 | $568.32 | 35.4% |
| 82274 | Stool analysis for blood, by fecal hemoglobin determination by immunoassay | Office | 2023 | 34 | 36 | $741.60 | $561.60 | 75.7% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 19 | 19 | $665.00 | $528.77 | 79.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 26 | 52 | $1,782 | $493.92 | 27.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 106 | 135 | $486.00 | $476.55 | 98.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 31 | 39 | $1,088 | $377.77 | 34.7% |
| 72100 | X-ray of lower and sacral spine, 2-3 views | Office | 2023 | 13 | 15 | $871.65 | $259.18 | 29.7% |
| 81001 | Manual urinalysis test with examination using microscope, automated | Office | 2023 | 51 | 74 | $492.84 | $230.14 | 46.7% |
| 73501 | X-ray of hip, 1 view | Office | 2023 | 13 | 15 | $693.15 | $227.08 | 32.8% |
| 73030 | X-ray of shoulder, minimum of 2 views | Office | 2023 | 12 | 13 | $632.32 | $208.32 | 32.9% |
| 86677 | Analysis for antibody to helicobacter pylori (gastrointestinal bacteria) | Office | 2023 | 12 | 12 | $2,373 | $198.12 | 8.3% |
| 74018 | X-ray of abdomen, 1 view | Office | 2023 | 11 | 12 | $517.20 | $144.10 | 27.9% |
| 82947 | Blood glucose (sugar) level | Office | 2023 | 18 | 22 | $176.22 | $84.70 | 48.1% |
| 17003 | Destruction of precancer skin growth, 2-14 growths | Office | 2023 | 12 | 13 | $117.26 | $51.48 | 43.9% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2022 | 265 | 432 | $6,839 | $3,293 | 48.1% |
| G0179 | Physician or allowed practitioner re-certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians a | Office | 2022 | 48 | 118 | $7,206 | $2,556 | 35.5% |
| 83036 | Hemoglobin a1c level | Office | 2022 | 105 | 172 | $3,404 | $1,643 | 48.3% |
| 0064A | Adm sarscov2 50mcg/0.25mlbst | Office | 2022 | 33 | 33 | $3,300 | $1,161 | 35.2% |
| 71046 | X-ray of chest, 2 views | Office | 2022 | 59 | 78 | $3,768 | $1,029 | 27.3% |
About Dr. Joe Wharton, MD
Dr. Joe Wharton, MD is a Family Medicine healthcare provider based in Warren, Arkansas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 05/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1225084577.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joe Wharton, MD has received a total of $4,367 in payments from pharmaceutical and medical device companies, with $425.40 received in 2024. These payments were reported across 321 transactions from 34 companies. The most common payment nature is "Food and Beverage" ($4,339).
As a Medicare-enrolled provider, Wharton has provided services to 2,028 Medicare beneficiaries, totaling 2,886 services with total Medicare billing of $35,065. Data is available for 4 years (2020–2023), covering 47 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Warren, AR
- Active Since 05/26/2006
- Last Updated 06/18/2021
- Taxonomy Code 207Q00000X
- Entity Type Individual
- Practice Solo Practitioner
- NPI Number 1225084577
Products in Payments
- VRAYLAR (Drug) $516.66
- UBRELVY (Drug) $353.74
- LINZESS (Drug) $193.18
- FARXIGA (Drug) $171.65
- ELIQUIS (Drug) $151.95
- QULIPTA (Drug) $149.63
- Ozempic (Drug) $142.91
- CHANTIX (Drug) $142.31
- ENTRESTO (Drug) $130.65
- JANUVIA (Drug) $127.28
- AIRSUPRA (Drug) $112.17
- CONTRAVE (Drug) $103.36
- VIAGRA (Drug) $94.46
- BYSTOLIC (Drug) $86.00
- INVOKANA (Drug) $82.72
- XARELTO (Drug) $75.26
- ANORO ELLIPTA (Drug) $74.23
- BELSOMRA (Drug) $72.42
- XIFAXAN (Drug) $72.21
- PREVNAR 13 (Biological) $71.44
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Warren
Ping Wang, Md, MD
Family Medicine — Payments: $127,206
Dr. Jason Rupeka, Do, DO
Family Medicine — Payments: $65,540
Dr. Jacob Bair, D.o, D.O
Family Medicine — Payments: $33,701
Saroj Misra, Do, DO
Family Medicine — Payments: $29,024
Dr. Kevin Agrest, Do, DO
Family Medicine — Payments: $14,748
Dr. Jeffrey Kraft, Do, DO
Family Medicine — Payments: $14,482